RxDoctor Payments Data

Jonathan Manhard, MD

Ophthalmology · South Burlington, VTNPI 1235526567

Payments from drug & device makers

What this record shows

Alcon accounts for 75.3% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $1,572, more than ten times the $65 reported in 2019. Among ophthalmology clinicians in VT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,211in general payments, 2019–2025

Across 26 payments — averaging $85.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$2K
  • Carl Zeiss Meditec USA, Inc.$187
  • Bausch & Lomb Americas Inc.$115
  • Rxsight Inc$113
  • Carl Zeiss Meditec, Inc.$65
  • Glaukos Corporation$48
  • plus $18 from 1 others

What the payments were for

  • Travel & lodging$1,11650%
  • Food & beverage$1,09450%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,211 in reported general payments places this provider in the 90th percentile of 35 ophthalmology providers in Vermont.

See all ophthalmology providers in Vermont

Medicare billing

Part B allowed, 2024
$277,998
Medicare patients
423
Services billed
1,635

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Bromfenac Sodium253$50,206
Prednisolone Acetate356$23,368
Travoprost13$4,927
Latanoprost131$1,638
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat63$1,199
Timolol Maleate100$1,071
Ketorolac Tromethamine42$991
Dorzolamide Hcl29$578
MoxifloxacinMoxifloxacin Hcl19$437
Brimonidine Tartrate13$250

Paid to pharmacies, not to this prescriber.

Other ophthalmology in South Burlington

See the full list for Vermont

Where these figures come from

Is this you, or does something look wrong? →